The antinociceptive effects of intravenous dexmedetomidine in colorectal distension-induced visceral pain in rats: The role of opioid receptors

Anesthesia and Analgesia

Volumn 109, Issue 2, 2009, Pages 616-622

  Ulger, Fatma ^a   Bozkurt, Ayhan ^b   Bilge, S Srr ^a   Ilkaya, Fatih ^a   Dilek, Ahmet ^a   Bostanci, M Ömer ^b   Çiftcioǧlu, Engin ^c   Güldoǧuş, Fuat ^a  

^a Department of Anesthesiology and Reanimation ^*

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^c HITIT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; DEXMEDETOMIDINE; N [2 (1,3,4,6,7,12B HEXAHYDRO 2' OXOSPIRO[2H BENZOFURO[2,3 A]QUINOLIZINE 2,4' IMIDAZOLIDIN] 3' YL)ETHYL]METHANESULFONAMIDE; NALOXONE; OPIATE RECEPTOR; YOHIMBINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; NARCOTIC ANTAGONIST; QUINOLIZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COLON DILATATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROMYOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VISCERAL PAIN; ANIMAL; BALLOON DILATATION; COLON; INTRAVENOUS DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; PHYSIOLOGY; RECTUM; SPRAGUE DAWLEY RAT; STATISTICAL ANALYSIS; STIMULATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANALGESICS, NON-NARCOTIC; ANIMALS; BALLOON DILATATION; CLONIDINE; COLON; DATA INTERPRETATION, STATISTICAL; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RECTUM; YOHIMBINE;

EID: 67849130660     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181a9fae2     Document Type: Article

References (40)

1. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985;22:845-858
2. Pertovaara A. Antinociception induced by-2-adrenoceptor agonists, with special emphasis on medetomidine studies. Prog Neurobiol 1993;40:691-709
3. Kingery WS, Davies MF, Maze M. Molecular mechanisms for the analgesic properties of alpha-2 adrenergic agonists. In: Borsook D, ed. Molecular neurobiology of pain. Seattle: IASP Press, 1997:275-304
4. Takano Y, Yaksh TL. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist. J Pharmacol Exp Ther 1991;258:438-446
5. Poree LR, Guo TZ, Kingery WS, Maze M. The analgesic potency of dexmedetomidine is enhanced after nerve injury: A possible role for peripheral alpha2-adrenoceptors. Anesth Analg 1998; 87:941-948
6. Guo TZ, Davies MF, Kingery WS, Patterson AJ, Limbird LE, Maze M. Nitrous oxide produces antinociceptive response via alpha2B and/or alpha2C adrenoceptor subtypes in mice. Anesthesiology 1999;90:470-476
7. Asano T, Dohi S, Ohta S, Shimonaka H, Iida H. Antinociception by epidural and systemic alpha(2)-adrenoceptor agonists and their binding affinity in rat spinal cord and brain. Anesth Analg 2000;90:400-407
8. Wei H, Jyväsjärvi E, Niissalo S, Hukkanen M, Waris E, Konttinen YT, Pertovaara A. The influence of chemical sympathectomy on pain responsivity and alpha 2-adrenergic antinociception in neuropathic animals. Neuroscience 2002;114:655-668
9. Paqueron X, Conklin D, Eisenach JC. Plasticity in action of intrathecal clonidine to mechanical but not thermal nociception after peripheral nerve injury. Anesthesiology 2003;99: 199-204
10. Dogrul A, Uzbay IT. Topical clonidine antinociception. Pain 2004;111:385-391
11. Guneli E, Karabay Yavasoglu NU, Apaydin S, Uyar M, Uyar M. Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain. Pharmacol Biochem Behav 2007;88:9-17
12. Gebhart GF, Ness TJ. Mechanisms of visceral pain. In: Bond MR, Charlton JE, Woolf CJ, eds. Proceedings of the VIth World Congress on Pain. Amsterdam: Elsevier, 1991:351-363
13. Cervero F, Laird J. Visceral pain. Lancet 1999;353:2145-2148
14. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: Physiologic and pharmacologic characterization of pseudoaffective reflexes in the rat. Brain Res 1988;450:153-169
15. Danzebrink RM, Gebhart GF. Antinociceptive effects of intrathecal adrenoceptor agonists in a rat model of visceral nociception. J Pharmacol Exp Ther 1990;253:698-705
16. Harada Y, Nishioka K, Kitahata LM, Kishikawa K, Collins JG. Visceral antinociceptive effects of spinal clonidine combined with morphine, [D-Pen2, D-Pen5] enkephalin, or U50,488H. Anesthesiology 1995;83:344-352
17. Miampamba M, Chéry-Croze S, Détolle-Sarbach S, Guez D, Chayvialle JA. Antinociceptive effects of oral clonidine and S12813-4 in acute colon inflammation in rats. Eur J Pharmacol 1996;308:251-259
18. Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors. I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther 2000;295:1192-1205 (Pubitemid 30951580)
19. Pertovaara A, Kalmari J. Comparison of the visceral antinociceptive effects of spinally administered MPV-2426 (fadolmidine) and clonidine in the rat. Anesthesiology 2003;98:189-194
20. Sabetkasaie M, Vala S, Khansefid N, Hosseini AR, Sadat Ladgevardi MA. Clonidine and guanfacine-induced antinociception in visceral pain: Possible role of alpha 2/I2 binding sites. Eur J Pharmacol 2004;501:95-101
21. Mansikka H, Lähdesmäki J, Scheinin M, Pertovaara A. Alpha(2A) adrenoceptors contribute to feedback inhibition of capsaicin-induced hyperalgesia. Anesthesiology 2004;101: 185-190
22. Brusberg M, Ravnefjord A, Lindgreen M, Larsson H, Lindström E, Martinez V. Oral clonidine inhibits visceral pain-related viscerosomatic and cardiovascular responses to colorectal distension in rats. Eur J Pharmacol 2008;591:243-251
23. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol 1997;273:G997-G1006
24. Malcolm A, Camilleri M, Kost L, Burton DD, Fett SL, Zinsmeister AR. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Aliment Pharmacol Ther 2000;14:783-793
25. Viramontes BE, Malcolm A, Camilleri M, Szarka LA, McKinzie S, Burton DD, Zinsmeister AR. 2001. Effects of an-2-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol 2001;281:G1468-1476
26. Tufanogullari B, White PF, Peixoto MP, Kianpour D, Lacour T, Griffin J, Skrivanek G, Macaluso A, Shah M, Provost DA. Dexmedetomidine infusion during laparoscopic bariatric surgery: The effect on recovery outcome variables. Anesth Analg 2008;106:1741-1748
27. Elvan EG, OçB, Uzun S, Karabulut E, Coçskun F, Aypar U. Dexmedetomidine and postoperative shivering in patients undergoing elective abdominal hysterectomy. Eur J Anaesthesiol 2008;25:357-364
28. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 1988;150:9-14
29. MacKenzie J. Symptoms and their interpretation. London: Shaw & Sons, 1909
30. Burton MB, Gebhart GF. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation. J Pharmacol Exp Ther 1998;285:707-715
31. Clineschmidt BV, Pettibone DJ, Lotti VJ, Hucker HB, Sweeney BM, Reiss DR, Lis EV, Hiff JR, Vacca J. A peripherally acting alpha-2 adrenoceptor antagonist: L659,066. J Pharmacol Exp Ther 1988;245:32-40
32. Buerkle H, Yaksh TL. Pharmacological evidence for different alpha 2-adrenergic receptor sites mediating analgesia and sedation in the rat. Br J Anaesth 1998;81:208-215
33. Bousquet P. Imidazoline receptors. Neurochem Int 1997;30:3-7
34. Parini A, Moudanos CG, Pizzinat N, Lanier SM. The elusive family of imidazoline binding sites. Trends Pharmacol Sci 1996;17:13-16
35. Nakamura M, Ferreira SH. Peripheral analgesic action of clonidine: Mediation by release of endogenous enkephalin-like substances. Eur J Pharmacol 1988;146:223-228
36. Kendig JJ, Savola MK, Woodley SJ, Maze M.-2-adrenoceptors inhibit a nociceptive response in neonatal rat spinal cord. Eur J Pharmacol 1991;192:293-300
37. Sullivan AF, Kalso EA, McQuay HJ, Dickenson AH. The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat. Eur J Pharmacol 1992; 215:127-133
38. Sabbe MB, Penning JP, Ozaki GT, Yaksh TL. Spinal and systemic action of the-2 receptor agonist dexmedetomidine in dogs. Antinociception and carbon dioxide response. Anesthesiology 1994;80:1057-1072
39. Otsuguro K, Yasutake S, Ohta T, Ito S. Effects of opioid receptor and-2-adrenoceptor agonists on slow ventral root potentials and on capsaicin and formalin tests in neonatal rats. Brain Res Dev Brain Res 2005;158:50-58
40. Vazquez J, Covenas R, Munoz M, Garcia JA, Victoria A. Modifications in the distribution of met-enkephalin in the cat spinal cord after administration of clonidine. An immunocytochemical study. Histol Histopathol 1998;13:955-959 (Pubitemid 28480352)